Padem, N., Wright, H., Fuleihan, R., Garabedian, E., Suez, D., Cunningham-Rundles, C., Marsh, R. A., & Khojah, A. (2022). Rheumatologic diseases in patients with inborn errors of immunity in the USIDNET registry. Clinical Rheumatology, 41(7), 2197–2203. https://doi.org/10.1007/s10067-021-06044-4

Droghini, H. R., Abonia, J. P., Collins, M. H., Milner, J. D., Lyons, J. J., Freeman, A. F., Mukkada, V. A., Risma, K. A., Rothenberg, M. E., & Schwartz, J. T. (2022). Targeted IL-4Rα blockade ameliorates refractory allergic eosinophilic inflammation in a patient with dysregulated TGF-β signaling due to ERBIN deficiency. The Journal of Allergy and Clinical Immunology: In Practice, 10(7), 1903–1906. https://doi.org/10.1016/j.jaip.2022.01.012

Ozdede, A., Guner, S., Ozcifci, G., Yurttas, B., Toker Dincer, Z., Atli, Z., Uygunoğlu, U., Durmaz, E., Uçar, D., Uğurlu, S., Saip, S., Tabak, F., Hamuryudan, V., & Seyahi, E. (2022). Safety of SARS-CoV-2 vaccination in patients with Behcet’s syndrome and familial Mediterranean fever: a cross-sectional comparative study on the effects of M-RNA based and inactivated vaccine. Rheumatology International, 42(6), 973–987. https://doi.org/10.1007/s00296-022-05119-y

Ozdede, A., Güner, S., Ozcifci, G., Yurttas, B., Toker Dincer, Z., Atli, Z., Uygunoglu, U., Durmaz, E., Ucar, D., Ugurlu, S., Saip, S., Tabak, Ö. F., Hamuryudan, V., & Seyahi, E. (2022). POS1255 SAFETY OF THE PFIZER/BIONTECH AND SINOVAC/CORONAVAC VACCINES AMONG PATIENTS WITH BEHCET’S SYNDROME AND FAMILIAL MEDITERRANEAN FEVER. Annals of the Rheumatic Diseases, 81, 962–963. https://doi.org/10.1136/annrheumdis-2022-eular.3711

O’Toole, D., Groth, D., Wright, H., Bonilla, F. A., Fuleihan, R. L., Cunningham-Rundles, C., Sullivan, K. E., Ochs, H. D., Marsh, R., & Feuille, E. (2022). X-Linked Agammaglobulinemia: Infection Frequency and Infection-Related Mortality in the USIDNET Registry. Journal of Clinical Immunology, 42(4), 827–836. https://doi.org/10.1007/s10875-022-01237-1

LaBere, B., Gutierrez, M. J., Wright, H., Garabedian, E., Ochs, H. D., Fuleihan, R. L., Secord, E., Marsh, R., Sullivan, K. E., Cunningham-Rundles, C., Notarangelo, L. D., & Chen, K. (2022). Chronic Granulomatous Disease With Inflammatory Bowel Disease: Clinical Presentation, Treatment, and Outcomes From the USIDNET Registry. The Journal of Allergy and Clinical Immunology: In Practice, 10(5), 1325-1333.e5. https://doi.org/10.1016/j.jaip.2021.12.035

Hoshino, A., Boutboul, D., Zhang, Y., Kuehn, H. S., Hadjadj, J., Özdemir, N., Celkan, T., Walz, C., Picard, C., Lenoir, C., Mahlaoui, N., Klein, C., Peng, X., Azar, A., Reigh, E., Cheminant, M., Fischer, A., Rieux-Laucat, F., Callebaut, I., … Latour, S. (2022). Gain-of-function IKZF1 variants in humans cause immune dysregulation associated with abnormal T/B cell late differentiation. Science Immunology, 7(69). https://doi.org/10.1126/sciimmunol.abi7160

Huang, J. J., Gaines, S. B., Amezcua, M. L., Lubell, T. R., Dayan, P. S., Dale, M., Boneparth, A. D., Hicar, M. D., Winchester, R., & Gorelik, M. (2022). Upregulation of type 1 conventional dendritic cells implicates antigen cross-presentation in multisystem inflammatory syndrome. Journal of Allergy and Clinical Immunology, 149(3), 912–922. https://doi.org/10.1016/j.jaci.2021.10.015

Callahan, E. A., Chatila, T., Deckelbaum, R. J., Field, C. J., Greer, F. R., Hernell, O., Järvinen, K. M., Kleinman, R. E., Milner, J., Neu, J., Smolen, K. K., & Wallingford, J. C. (2022). Assessing the safety of bioactive ingredients in infant formula that affect the immune system: recommendations from an expert panel. The American Journal of Clinical Nutrition, 115(2), 570–587. https://doi.org/10.1093/ajcn/nqab346

Guglielmo-Roxby, T., Louissaint, V., Ettinger, A., Llanos, A., Cahill, E., Chefitz, D., Boneparth, A., Amato, I., & Moorthy, L. N. (2021). Assessment of Resident Knowledge in Pediatric Rheumatology. Global Pediatric Health, 8. https://doi.org/10.1177/2333794x211062020